Adam CM, Wetzel TJ, Erfan SC, Wheeler LM, et al. Blocking mitochondrial leucine transamination enhances T-cell activation and improves T-cell immunity against OVA-producing EL4 lymphoma. Br J Cancer 2026 May 5. doi: 10.1038/s41416-026-03455.
PMID: 42086670